Summary
- Current Price
- ITOS price is unknown, with unknown change on
- Current Price All-Time High
- ITOS price vs all-time high is unknown
- Market Cap
- ITOS market cap is unknown, with unknown 1-year change
- PE Ratio
- ITOS PE ratio is unknown
- Revenue
- ITOS current annual revenue is $35.00M, up +177.89% year-over-year
- Next Earnings
- As of today, the next earnings release for ITOS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | iTeos Therapeutics, Inc. |
| Ticker | NASDAQ: ITOS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | iteostherapeutics.com |
| Employees | 173 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $35M | ||
| Revenue, 1Y Change | +177.89% | |
| -$3.32 | ||
| EPS, 1Y Change | -5.40% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.32 | ||
| EPS Estimate | N/A | -$3.84 |
| EPS Est. Change | N/A | -15.66% |
| $35.00M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| - | ||
| Price Target | - | $10.05 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.40 | -$3.15 | +7.35% | |
| -$3.15 | -$3.32 | -5.49% | |
| -$3.84 | N/A | -15.66% | |
| -$2.69 | N/A | +19.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.59M | $12.60M | +0.04% | |
| $35.00M | $35.00M | 0.00% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +177.89% | ||
| -89.85% | ||
| -5.40% | ||
| -158.45% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $35.00M | ||
| -$3.32 | ||
| $33.76M | ||
| 96.46% | ||
| -$154.33M | ||
| -455.79% | ||
| -$134.41M | ||
| -384.04% | ||
| -$153.09M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 12.62 | ||
| 12.62 | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $590.29M | ||
| $142.13M | ||
| $686.98M | ||
| $509.54M | ||
| $96.68M | ||
| $40.36M | ||
| $5.10M | ||
| $1.34M | ||
| $8.50M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $189.33M | ||
| $189.33M | ||
| $1.24M | ||
| $49.08M | ||
| $1.24M | ||
| $0.00 | ||
| $14.07M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$98.18M | ||
| -$131.15M | ||
| $122.24M | ||
| $1.66M | ||
| -$99.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| Wells Fargo | → | |
| Piper Sandler | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| Wells Fargo | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with ITOS
FAQ
What is the ticker symbol for iTeos Therapeutics, Inc.?
The ticker symbol for iTeos Therapeutics, Inc. is NASDAQ:ITOS
Does iTeos Therapeutics, Inc. pay dividends?
No, iTeos Therapeutics, Inc. does not pay dividends
What sector is iTeos Therapeutics, Inc. in?
iTeos Therapeutics, Inc. is in the Healthcare sector
What industry is iTeos Therapeutics, Inc. in?
iTeos Therapeutics, Inc. is in the Biotechnology industry
What country is iTeos Therapeutics, Inc. based in?
iTeos Therapeutics, Inc. is headquartered in United States
When did iTeos Therapeutics, Inc. go public?
iTeos Therapeutics, Inc. initial public offering (IPO) was on July 24, 2020
Is iTeos Therapeutics, Inc. in the S&P 500?
No, iTeos Therapeutics, Inc. is not included in the S&P 500 index
Is iTeos Therapeutics, Inc. in the NASDAQ 100?
No, iTeos Therapeutics, Inc. is not included in the NASDAQ 100 index
Is iTeos Therapeutics, Inc. in the Dow Jones?
No, iTeos Therapeutics, Inc. is not included in the Dow Jones index
When was iTeos Therapeutics, Inc. last earnings report?
iTeos Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does iTeos Therapeutics, Inc. report earnings?
The date for iTeos Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ITOS Official Website www.iteostherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1808865/000095017025033066/0000950170-25-033066-index.htm
- ITOS Profile on Yahoo Finance finance.yahoo.com/quote/ITOS
- ITOS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/itos